Evidence map›Paper›PMID 34680045›Full record

ArticleBiomolecules2021

Deficiency of the Lysosomal Protein CLN5 Alters Lysosomal Function and Movement.

Indranil Basak, Rachel A Hansen, Michael E Ward, Stephanie M Hughes

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Generation of Donor-Specific iPSC for Modelling Lysosomal Storage Disorders.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The landscape of CRISPR/Cas9 for inborn errors of metabolism.Molecular genetics and metabolism · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. An altered transcriptome underliesFrontiers in genetics · 2022
    Article
  15. Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).Frontiers in cell and developmental biology · 2022
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Indranil BasakBrain Health Research Centre and Genetics Otago, Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin 9011, New Zealand.ORCID 0000-0001-5009-2845
Rachel A HansenBrain Health Research Centre and Genetics Otago, Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin 9011, New Zealand.
Michael E WardNational Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD 20814, USA.
Stephanie M HughesBrain Health Research Centre and Genetics Otago, Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin 9011, New Zealand.
University of Otago · NZNational Institute of Neurological Disorders and Stroke · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Batten disease is a devastating, childhood, rare neurodegenerative disease characterised by the rapid deterioration of cognition and movement, leading to death within ten to thirty years of age. One of the thirteen Batten disease forms,

Indexed as

AdolescentAdultCathepsin BCell LineCerebellar CortexChildCRISPR-Cas SystemsHumansInduced Pluripotent Stem CellsLysosomal Membrane ProteinsLysosomesMutationNeurodegenerative DiseasesNeuronal Ceroid-LipofuscinosesNeuronsPhenotypeCathepsin BCLN5 protein, humanLysosomal Membrane ProteinsBatten diseasecathepsin BCLN5CRISPRiPSC-derived human neuronslysosome aciditylysosome enzyme activitylysosome functionlysosome movement

Identifiers

PMID34680045
PMCPMC8533494
OpenAlexW3202402165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.